In this primer for patients, their families, and their doctors, a leading physician and scientist explains why the standard treatment for hypothyroidism fails many-and offers an empowering call for change. Hypothyroidism, also commonly referred to as Hashimoto's disease, affects millions in the United States alone. It occurs when the thyroid-the butterfly-shaped gland that sits in your neck right above the front of your shirt collar-malfunctions or after thyroid surgery, causing thyroid hormone levels in circulation to ...
Read More
In this primer for patients, their families, and their doctors, a leading physician and scientist explains why the standard treatment for hypothyroidism fails many-and offers an empowering call for change. Hypothyroidism, also commonly referred to as Hashimoto's disease, affects millions in the United States alone. It occurs when the thyroid-the butterfly-shaped gland that sits in your neck right above the front of your shirt collar-malfunctions or after thyroid surgery, causing thyroid hormone levels in circulation to drop below normal. Thus, treatment is aimed at bringing these hormone levels back to normal. This is done with daily tablets of thyroxine or T4. Because hypothyroidism is so common, we likely know someone who is on this type of medication. While most patients respond well to this standard treatment, about ten to twenty percent (some two to three million individuals in the United States) are far from living a typical life. They exhibit "foggy brain"-low energy, confusion, and poor memory. Many doctors have shrugged off their complaints, believing these symptoms to be unrelated to the thyroid disease. In Rethinking Hypothyroidism, Dr. Antonio C. Bianco, a physician and a scientist who has studied hypothyroidism and thyroid hormones for decades, offers an accessible overview of the disease's treatment and the role of big pharma in shaping it, making the case that the current approach is failing many patients. But more than this, Bianco calls for alternatives to improve lives, and he equips patients and their families with the tools to advocate for other treatments.
Read Less
Add this copy of Rethinking Hypothyroidism: Why Treatment Must Change to cart. $15.56, new condition, Sold by GreatBookPrices rated 4.0 out of 5 stars, ships from Columbia, MD, UNITED STATES, published 2022 by University of Chicago Press.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
New. Trade paperback (US). Glued binding. 304 p. In Stock. 100% Money Back Guarantee. Brand New, Perfect Condition, allow 4-14 business days for standard shipping. To Alaska, Hawaii, U.S. protectorate, P.O. box, and APO/FPO addresses allow 4-28 business days for Standard shipping. No expedited shipping. All orders placed with expedited shipping will be cancelled. Over 3, 000, 000 happy customers.
Add this copy of Rethinking Hypothyroidism: Why Treatment Must Change to cart. $15.57, new condition, Sold by Ingram Customer Returns Center rated 5.0 out of 5 stars, ships from NV, USA, published 2022 by University of Chicago Press.
Add this copy of Rethinking Hypothyroidism: Why Treatment Must Change to cart. $25.00, new condition, Sold by Russell Books rated 4.0 out of 5 stars, ships from Victoria, BC, CANADA, published 2022 by University of Chicago Press.
Add this copy of Rethinking Hypothyroidism: Why Treatment Must Change to cart. $26.30, new condition, Sold by Paperbackshop rated 4.0 out of 5 stars, ships from Bensenville, IL, UNITED STATES, published 2022 by University of Chicago Press.
Add this copy of Rethinking Hypothyroidism: Why Treatment Must Change to cart. $31.83, new condition, Sold by Booksplease rated 3.0 out of 5 stars, ships from Southport, MERSEYSIDE, UNITED KINGDOM, published 2022 by University of Chicago Press.
